Tozorakimab, CAS 2376858-66-9

Product Description: Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab reduces inflammation and epithelial dysfunction. Tozorakimab can be used to research chronic obstructive pulmonary disease[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Reid F, et al. Safety, pharmacokinetics and immunogenicity of the anti-interleukin-33 antibody, tozorakimab: results of a phase 1 study in healthy adults and patients with chronic obstructive pulmonary disease. American Thoracic Society. 2022: A2398-A2398. /[2]England E, et al. Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction. Sci Rep. 2023 Jun 17;13(1):9825.

CAS Number: 2376858-66-9

Molecular Weight: N/A

Compound Purity: 96.03

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Interleukin Related

• Artikelnummer: MEXHY-P99550-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99550-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK